文献速递艾滋病与性传播感染

一次性快速即时PCR设备检测淋球菌、沙眼衣原体和阴道毛滴虫的性能:横断面研究

Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.
PubMed 文献 · Lancet Infect Dis · 2020-11-23

本研究在美国七个州十个临床点纳入1585名14岁及以上女性,评估Visby Medical性健康检测(一次性即时PCR设备)对沙眼衣原体、淋病奈瑟菌和阴道毛滴虫的检测性能。结果显示该设备对三种病原体的敏感性和特异性均较高。

核心结论

  • 该一次性即时PCR设备检测沙眼衣原体、淋病奈瑟菌和阴道毛滴虫具有很高的敏感性和特异性。
  • 该设备可能代表性传播感染和其他传染病快速诊断的重要进展。

研究设计与样本

  • 横断面单次访视研究,2019年2月25日至2020年1月6日在美国七个州十个临床点连续纳入14岁及以上女性。
  • 患者感染状态通过临床医生采集的阴道标本使用Hologic Aptima Combo 2、Aptima Trichomonas vaginalis、BD ProbeTec CT/GC Qx、BD ProbeTec Trichomonas vaginalis Qx检测确定,结果不一致时用BD MAX CT/GC/TV作为仲裁。
  • 主要结局为研究设备检测三种病原体与患者感染状态相比的敏感性和特异性。

临床怎么用

  • 该设备可由未经培训的操作者使用,标本需在采集后2小时内运行。
  • 适用于女性自采阴道拭子样本的即时检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Timely detection and treatment are important for the control of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. The objective of this study was to measure the performance of the Visby Medical Sexual Health Test, a single-use, point-of-care PCR device. METHODS: Women aged 14 years and older who presented consecutively to ten clinical sites across seven US states were enrolled for a cross-sectional, single-visit study. Patients who consented to participate, and who had not used any exclusionary products in the genital area in the previous 48 h, provided self-collected vaginal swabs for testing with the investigational device. Untrained operators received the specimens and ran the device using the guide provided. Specimens had to be run within 2 h of collection to be considered valid. For comparison, patient-infected status was derived by testing clinician-collected vaginal specimens with the Hologic Aptima Combo 2 Assay and Aptima Trichomonas vaginalis Assay, as well as the BD ProbeTec CT/GC Qx Amplified DNA Assay and BD ProbeTec Trichomonas vaginalis Qx Assay. If the results of those assays did not match, the BD MAX CT/GC/TV was used as a tiebreaker. The primary outcomes were the sensitivity and specificity of the investigational device for the detection of C trachomatis, N gonorrhoeae, and T vaginalis compared with patient-infected status. FINDINGS: Between Feb 25, 2019, and Jan 6, 2020, 1585 participants aged between 14 years and 80 years (mean 34·8 [SD 14·2]) were enrolled. 1555 participants had tests run with the investigational device, of whom 1532 (98·5%) had a valid result on either the first or repeat test. Among the patients with evaluable results (including a determinate patient-infected status), the device had a sensitivity of 97·6% (95% CI 93·2-99·2) and specificity of 98·3% (97·5-98·9) for C trachomatis (n=1457), sensitivity of 97·4% (86·5-99·5) and specificity of 99·4% (98·9-99·7) for N gonorrhoeae (n=1468), and sensitivity of 99·2% (95·5-99·9) and specificity of 96·9% (95·8-97·7) for T vaginalis (n=1449). INTERPRETATION: This innovative, rapid, easy-to-use, single-use, point-of-care device to detect C trachomatis, N gonorrhoeae, and T vaginalis infections showed excellent sensitivity and specificity, and could represent an important advance in the development of rapid diagnostics for sexually transmitted infections and other infectious diseases. FUNDING: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Morris SR, Bristow CC, Wierzbicki MR, et al. Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study. Lancet Infect Dis. 2020. PMID: 33242473. doi:10.1016/S1473-3099(20)30734-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。